SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bruce Rosen who wrote (6303)4/8/1999 9:21:00 AM
From: Tatnic  Read Replies (2) of 7041
 
The DLJ analyst following Schering issued a report yesterday. He estimated that if approved, Vasomax would generate $30 million in sales in the latter part of 1999 and $100 million or more next year.
===============
That's a big IF. Just curious, how do they go from no approval to making $100 million? That's a stretch imo, but I'll leave that arguement to the people who care about the fundamentals. I see a technically weak stock.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News